Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Short-term versus long-term antibiotic prophylaxis after caesarean section
PACTR202509878761358Not yet recruiting
- Sponsor
- Victor Arimieye, MD, Inc.
- Start
- Sep 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of metronidazole in postpartum infection, surgical site infection (SSI) and endometritis, sponsored by Victor Arimieye, MD, Inc. Primary endpoint: Proportion of women with post-caesarean section surgical site infections. Planned start Sep 2025; status: not yet recruiting.
02
Drugs
metronidazole
03
Conditions
postpartum infectionsurgical site infection (SSI)endometritis
Beyond the preview
Go deeper on PACTR202509878761358.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202509878761358.